Astrana Health Statistics
Total Valuation
Astrana Health has a market cap or net worth of $1.93 billion. The enterprise value is $2.52 billion.
| Market Cap | 1.93B |
| Enterprise Value | 2.52B |
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Astrana Health has 49.58 million shares outstanding. The number of shares has increased by 2.40% in one year.
| Current Share Class | 49.58M |
| Shares Outstanding | 49.58M |
| Shares Change (YoY) | +2.40% |
| Shares Change (QoQ) | -0.96% |
| Owned by Insiders (%) | 10.28% |
| Owned by Institutions (%) | 60.32% |
| Float | 37.63M |
Valuation Ratios
The trailing PE ratio is 64.01 and the forward PE ratio is 27.12. Astrana Health's PEG ratio is 0.33.
| PE Ratio | 64.01 |
| Forward PE | 27.12 |
| PS Ratio | 0.55 |
| Forward PS | 0.46 |
| PB Ratio | 2.38 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 12.47 |
| P/OCF Ratio | 11.64 |
| PEG Ratio | 0.33 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.78, with an EV/FCF ratio of 16.26.
| EV / Earnings | 83.34 |
| EV / Sales | 0.71 |
| EV / EBITDA | 15.78 |
| EV / EBIT | 23.94 |
| EV / FCF | 16.26 |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 1.84.
| Current Ratio | 1.35 |
| Quick Ratio | 1.31 |
| Debt / Equity | 1.84 |
| Debt / EBITDA | 6.26 |
| Debt / FCF | 6.87 |
| Interest Coverage | 1.65 |
Financial Efficiency
Return on equity (ROE) is 5.66% and return on invested capital (ROIC) is 5.53%.
| Return on Equity (ROE) | 5.66% |
| Return on Assets (ROA) | 3.57% |
| Return on Invested Capital (ROIC) | 5.53% |
| Return on Capital Employed (ROCE) | 6.52% |
| Weighted Average Cost of Capital (WACC) | 7.57% |
| Revenue Per Employee | $1.18M |
| Profits Per Employee | $10,077 |
| Employee Count | 3,000 |
| Asset Turnover | 1.91 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Astrana Health has paid $18.73 million in taxes.
| Income Tax | 18.73M |
| Effective Tax Rate | 37.67% |
Stock Price Statistics
The stock price has increased by +43.41% in the last 52 weeks. The beta is 0.99, so Astrana Health's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | +43.41% |
| 50-Day Moving Average | 29.98 |
| 200-Day Moving Average | 27.17 |
| Relative Strength Index (RSI) | 70.89 |
| Average Volume (20 Days) | 505,863 |
Short Selling Information
The latest short interest is 2.86 million, so 5.77% of the outstanding shares have been sold short.
| Short Interest | 2.86M |
| Short Previous Month | 2.68M |
| Short % of Shares Out | 5.77% |
| Short % of Float | 7.60% |
| Short Ratio (days to cover) | 6.43 |
Income Statement
In the last 12 months, Astrana Health had revenue of $3.53 billion and earned $30.23 million in profits. Earnings per share was $0.61.
| Revenue | 3.53B |
| Gross Profit | 375.95M |
| Operating Income | 105.24M |
| Pretax Income | 49.71M |
| Net Income | 30.23M |
| EBITDA | 159.62M |
| EBIT | 105.24M |
| Earnings Per Share (EPS) | $0.61 |
Balance Sheet
The company has $478.38 million in cash and $1.07 billion in debt, with a net cash position of -$586.81 million or -$11.83 per share.
| Cash & Cash Equivalents | 478.38M |
| Total Debt | 1.07B |
| Net Cash | -586.81M |
| Net Cash Per Share | -$11.83 |
| Equity (Book Value) | 577.46M |
| Book Value Per Share | 16.35 |
| Working Capital | 258.73M |
Cash Flow
In the last 12 months, operating cash flow was $166.03 million and capital expenditures -$11.04 million, giving a free cash flow of $154.99 million.
| Operating Cash Flow | 166.03M |
| Capital Expenditures | -11.04M |
| Depreciation & Amortization | 54.38M |
| Net Borrowing | 628.28M |
| Free Cash Flow | 154.99M |
| FCF Per Share | $3.13 |
Margins
Gross margin is 10.66%, with operating and profit margins of 2.98% and 0.86%.
| Gross Margin | 10.66% |
| Operating Margin | 2.98% |
| Pretax Margin | 1.41% |
| Profit Margin | 0.86% |
| EBITDA Margin | 4.53% |
| EBIT Margin | 2.98% |
| FCF Margin | 4.40% |
Dividends & Yields
Astrana Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.40% |
| Shareholder Yield | -2.40% |
| Earnings Yield | 1.56% |
| FCF Yield | 8.02% |
Analyst Forecast
The average price target for Astrana Health is $44.56, which is 14.32% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $44.56 |
| Price Target Difference | 14.32% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 11.01% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Astrana Health has an Altman Z-Score of 2.41 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.41 |
| Piotroski F-Score | 5 |